STELARA 130 mg concentrate for solution for infusion | medicines.ie

Company: Janssen Sciences Ireland (a Johnson & Johnson Company)
Active Ingredient: Ustekinumab
Strength: Ustekinumab: 130 mg
Dosage Form: Concentrate for solution for infusion
Legal Category: A - prescription, may not be renewed
Last Updated: 25/09/2026

Licence numbers with strength, ATC code and dosage form
Licence number	Strength	ATC Code	Dosage Form
EU/1/08/494/005	130 mg	L04AC05	Concentrate for solution for infusion

Licence number: EU/1/08/494/005
Strength: 130 mg
ATC Code: L04AC05
Dosage Form: Concentrate for solution for infusion

Janssen Sciences Ireland (a Johnson & Johnson Company)

Janssen Sciences Ireland UC, Barnahely, Ringaskiddy, IRL - Co. Cork P43 FA46, P43 FA46 Ringaskiddy

Website: https://innovativemedicine.jnj.com/ireland/
Telephone: +3531800709122
Email: medinfo@its.jnj.com